BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10747964)

  • 1. Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B.
    Faber C; Sticht H; Schweimer K; Rösch P
    J Biol Chem; 2000 Jul; 275(27):20660-6. PubMed ID: 10747964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
    Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
    Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualizing a specific contact in the HIV-1 Tat protein fragment and trans-activation responsive region RNA complex by photocross-linking.
    Liu Y; Wang Z; Rana TM
    J Biol Chem; 1996 Apr; 271(17):10391-6. PubMed ID: 8626612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
    Du Z; Lind KE; James TL
    Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.
    Davidson A; Leeper TC; Athanassiou Z; Patora-Komisarska K; Karn J; Robinson JA; Varani G
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11931-6. PubMed ID: 19584251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge.
    Aboul-ela F; Karn J; Varani G
    Nucleic Acids Res; 1996 Oct; 24(20):3974-81. PubMed ID: 8918800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
    Richter S; Cao H; Rana TM
    Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neamine dimers targeting the HIV-1 TAR RNA.
    Riguet E; Désiré J; Boden O; Ludwig V; Göbel M; Bailly C; Décout JL
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4651-5. PubMed ID: 16153833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAR-RNA recognition by a novel cyclic aminoglycoside analogue.
    Raghunathan D; Sánchez-Pedregal VM; Junker J; Schwiegk C; Kalesse M; Kirschning A; Carlomagno T
    Nucleic Acids Res; 2006; 34(12):3599-608. PubMed ID: 16855296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Click dimers to target HIV TAR RNA conformation.
    Kumar S; Kellish P; Robinson WE; Wang D; Appella DH; Arya DP
    Biochemistry; 2012 Mar; 51(11):2331-47. PubMed ID: 22339203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic ensemble view of the conformational landscape of HIV-1 TAR RNA and allosteric recognition.
    Lu J; Kadakkuzha BM; Zhao L; Fan M; Qi X; Xia T
    Biochemistry; 2011 Jun; 50(22):5042-57. PubMed ID: 21553929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.
    Litovchick A; Lapidot A; Eisenstein M; Kalinkovich A; Borkow G
    Biochemistry; 2001 Dec; 40(51):15612-23. PubMed ID: 11747436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1999 Aug; 38(31):10059-69. PubMed ID: 10433713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors.
    Chavali SS; Mali SM; Jenkins JL; Fasan R; Wedekind JE
    J Biol Chem; 2020 Dec; 295(49):16470-16486. PubMed ID: 33051202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.
    Churcher MJ; Lamont C; Hamy F; Dingwall C; Green SM; Lowe AD; Butler JG; Gait MJ; Karn J
    J Mol Biol; 1993 Mar; 230(1):90-110. PubMed ID: 8450553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural rearrangements on HIV-1 Tat (32-72) TAR complex formation.
    Metzger AU; Schindler T; Willbold D; Kraft M; Steegborn C; Volkmann A; Frank RW; Rosch P
    FEBS Lett; 1996 Apr; 384(3):255-9. PubMed ID: 8617366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major groove opening at the HIV-1 Tat binding site of TAR RNA evidenced by a rhodium probe.
    Neenhold HR; Rana TM
    Biochemistry; 1995 May; 34(19):6303-9. PubMed ID: 7756257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.